MACROGENICS INC — Director's Dealing 2018

Mar 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-03-02

Reporting Person: Risser Eric Blasius (Sr VP & Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-02	Common Stock	M	4000	$0.94	Acquired	13100	Direct
2018-03-02	Common Stock	S	4000	$30	Disposed	9100	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-02	Employee stock option (right to buy)	$28.94	A	70000	Acquired	2028-03-02	Common Stock (70000.0)	Direct
2018-03-05	Employee stock option (right to buy)	$0.94	M	4000	Disposed	2019-03-23	Common Stock (4000.0)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2017.

F2: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.05.The price reported above reflects the weighted average sale price on the date indicated. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.